Match!

Whole–genome characterization of chemoresistant ovarian cancer

Published on May 1, 2015in Nature43.07
· DOI :10.1038/nature14410
Ann-Marie Patch32
Estimated H-index: 32
(UQ: University of Queensland),
Elizabeth L. Christie8
Estimated H-index: 8
(Peter MacCallum Cancer Centre)
+ 79 AuthorsDavid D.L. Bowtell74
Estimated H-index: 74
(Imperial College London)
Sources
Abstract
Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. We show that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance. CCNE1 amplification was common in primary resistant and refractory disease. We observed several molecular events associated with acquired resistance, including multiple independent reversions of germline BRCA1 or BRCA2 mutations in individual patients, loss of BRCA1 promoter methylation, an alteration in molecular subtype, and recurrent promoter fusion associated with overexpression of the drug efflux pump MDR1.
  • References (62)
  • Citations (484)
📖 Papers frequently viewed together
200543.07Nature
14 Authors (Hannah Farmer, ..., Alan Ashworth)
3,482 Citations
200843.07Nature
589 Citations
271 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References62
Newest
#1Bettina Meier (Dund.: University of Dundee)H-Index: 11
#2Susanna L. Cooke (Wellcome Trust Sanger Institute)H-Index: 25
Last. Peter J. Campbell (University of Cambridge)H-Index: 95
view all 12 authors...
Mutation is associated with developmental and hereditary disorders, aging, and cancer. While we understand some mutational processes operative in human disease, most remain mysterious. We used Caenorhabditis elegans whole-genome sequencing to model mutational signatures, analyzing 183 worm populations across 17 DNA repair-deficient backgrounds propagated for 20 generations or exposed to carcinogens. The baseline mutation rate in C. elegans was approximately one per genome per generation, not ove...
92 CitationsSource
#1Katia Nones (UQ: University of Queensland)H-Index: 30
#2Nic Waddell (UQ: University of Queensland)H-Index: 20
Last. Sean M. Grimmond (Glas.: University of Glasgow)H-Index: 71
view all 38 authors...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly being appreciated. To define the genome-wide pattern of DNA methylation in pancreatic ductal adenocarcinomas (PDAC), we captured the methylation profiles of 167 untreated resected PDACs and compared them to a panel of 29 adjacent nontransformed pancreata using high-density arrays. A total of 11,634 CpG sites associated with 3,522 genes were significantly differentially methylated (DM) in PDAC and ...
85 CitationsSource
#1Kalpana Kannan (BCM: Baylor College of Medicine)H-Index: 5
#2Cristian Coarfa (BCM: Baylor College of Medicine)H-Index: 40
Last. Laising Yen (BCM: Baylor College of Medicine)H-Index: 10
view all 7 authors...
Ovarian cancer is the fifth leading cause of cancer death in women. Almost 70% of ovarian cancer deaths are due to the high-grade serous subtype, which is typically detected only after it has metastasized. Characterization of high-grade serous cancer is further complicated by the significant heterogeneity and genome instability displayed by this cancer. Other than mutations in TP53, which is common to many cancers, highly recurrent recombinant events specific to this cancer have yet to be identi...
22 CitationsSource
#1Akinyemi I. Ojesina (Harvard University)H-Index: 23
#2Lee Lichtenstein (Harvard University)H-Index: 16
Last. Matthew MeyersonH-Index: 160
view all 56 authors...
To provide an overview of the genomic aberrations that contribute to cervical cancer these authors performed whole-exome sequencing and analysis of 115 cervical cancernormal pairs, transcriptome sequences of 79 cervical carcinomas and whole-genomes from 14 cervical cancernormal pairs. Analyses identify MAPK1, HLA-B and ELF3 as novel significantly mutated genes and provide evidence that human papilloma virus integration is a common mechanism for target gene overexpression in cervical cancer. The ...
330 CitationsSource
#1Michael S. LawrenceH-Index: 96
#2Petar StojanovH-Index: 35
Last. Gad GetzH-Index: 137
view all 10 authors...
Although a few cancer genes are mutated in a high proportion of tumours of a given type (.20%), most are mutated at intermediate frequencies (2–20%). To explore the feasibility of creating a comprehensive catalogue of cancer genes, we analysed somatic point mutations in exome sequences from 4,742 human cancers and their matched normal-tissue samples across 21 cancer types. We found that large-scale genomic analysis can identify nearly all known cancer genes in these tumour types. Our analysis al...
1,491 CitationsSource
#1Brett E. Johnson (UCSF: University of California, San Francisco)H-Index: 8
#2Tali Mazor (UCSF: University of California, San Francisco)H-Index: 10
Last. Joseph F. Costello (UCSF: University of California, San Francisco)H-Index: 58
view all 34 authors...
After surgery, gliomas (a type of brain tumor) recur in nearly all patients and often in a more aggressive form. Johnson et al. (p. [189][1], published online 12 December 2013) used exome sequencing to explore whether recurrent tumors harbor different mutations than the primary tumors and whether the mutational profile in the recurrences is influenced by postsurgical treatment of patients with temozolomide (TMZ), a chemotherapeutic drug known to damage DNA. In more than 40% of cases, at least ha...
607 CitationsSource
#1Karin S. Kassahn (UQ: University of Queensland)H-Index: 25
#2Oliver Holmes (UQ: University of Queensland)H-Index: 13
Last. John V. Pearson (UQ: University of Queensland)H-Index: 48
view all 34 authors...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficulties of distinguishing true somatic events from artifacts arising from PCR, sequencing errors or mis-mapping. Tumor cellularity or purity, sub-clonality and copy number changes also confound the identification of true somatic events against a background of germline variants. We have developed a heuristic strategy and software (http://www.qcmg.org/bioinformatics/qsnp/) for somatic mutation calling...
34 CitationsSource
#1Giovanni CirielloH-Index: 34
#2Martin L. MillerH-Index: 21
Last. Christian A. SanderH-Index: 149
view all 6 authors...
Cancer therapy is challenged by the diversity of molecular implementations of oncogenic processes and by the resulting variation in therapeutic responses. Projects such as The Cancer Genome Atlas (TCGA) provide molecular tumor maps in unprecedented detail. The interpretation of these maps remains a major challenge. Here we distilled thousands of genetic and epigenetic features altered in cancers to ~500 selected functional events (SFEs). Using this simplified description, we derived a hierarchic...
681 CitationsSource
#1Charlotte Wilhelm-Benartzi (Imperial College London)H-Index: 13
#2Devin C. Koestler (Dartmouth College)H-Index: 30
Last. Robert Brown (Imperial College London)H-Index: 62
view all 9 authors...
The promise of epigenome-wide association studies and cancer-specific somatic DNA methylation changes in improving our understanding of cancer, coupled with the decreasing cost and increasing coverage of DNA methylation microarrays, has brought about a surge in the use of these technologies. Here, we aim to provide both a review of issues encountered in the processing and analysis of array-based DNA methylation data and a summary of the advantages of recent approaches proposed for handling those...
86 CitationsSource
#1Ali BashashatiH-Index: 28
#2Gavin HaH-Index: 37
Last. Sohrab P. Shah (UBC: University of British Columbia)H-Index: 51
view all 25 authors...
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to the emergence of treatment-resistant subclones. We sought to measure the degree of genomic diversity within primary, untreated HGSCs to examine the natural state of tumour evolution prior to therapy. We performed exome sequencing, copy number analysis, targeted amplicon deep sequencing and gene expression profiling on 31 spatially and temporally separated HGSC tumour specimens (six patients), including ...
218 CitationsSource
Cited By484
Newest
#1Hanna Engqvist (University of Gothenburg)H-Index: 2
#2Toshima Z. Parris (University of Gothenburg)H-Index: 12
Last. Khalil Helou (University of Gothenburg)H-Index: 22
view all 9 authors...
Ovarian cancer comprises multiple subtypes (clear-cell (CCC), endometrioid (EC), high-grade serous (HGSC), low-grade serous (LGSC), and mucinous carcinomas (MC)) with differing molecular and clinical behavior. However, robust histotype-specific biomarkers for clinical use have yet to be identified. Here, we utilized a multi-omics approach to identify novel histotype-specific genetic markers associated with ovarian carcinoma histotypes (CCC, EC, HGSC, and MC) using DNA methylation, DNA copy numbe...
Source
#1Ailith Ewing (Edin.: University of Edinburgh)
#2Alison Meynert (Edin.: University of Edinburgh)H-Index: 7
Last. Michelle Ferguson (Dund.: University of Dundee)H-Index: 2
view all 29 authors...
Around half of high grade serous ovarian carcinomas (HGSOC) show homologous recombination repair deficiency (HRD), often caused by germline or somatic single nucleotide variant (SNV) mutations or small indels disrupting BRCA1/2. We have uniformly processed the largest collection of whole genome sequencing (WGS) data from HGSOC samples to date (N=205), comprehensively characterising the somatic mutational landscape, and expression at the BRCA1/2 loci. We discover that large structural variants (S...
Source
#1Angela My Chan (TBCC: Tom Baker Cancer Centre)
#2Emeka K. Enwere (TBCC: Tom Baker Cancer Centre)H-Index: 5
Last. Peter F. Rambau (Catholic University of Health and Allied Sciences)H-Index: 14
view all 19 authors...
CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification status and to validate whether CCNE1 high-level amplification and overexpression are prognostic in HGSC. A testing set of 528 HGSC samples stained with two optimised IHC assays (clones EP126 and HE12) was subjected to digital image analysis and visual scoring. D...
Source
#1Sohrab SalehiH-Index: 1
#2Farhia KabeerH-Index: 1
Last. Jazmine BrimhallH-Index: 3
view all 31 authors...
Tumour fitness landscapes underpin selection in cancer, impacting etiology, evolution and response to treatment. Progress in defining fitness landscapes has been impeded by a lack of timeseries perturbation experiments over realistic intervals at single cell resolution. We studied the nature of clonal dynamics induced by genetic and pharmacologic perturbation with a quantitative fitness model developed to ascribe quantitative selective coefficients to individual cancer clones, enable prediction ...
1 CitationsSource
#1Caroline E. Ford (UNSW: University of New South Wales)H-Index: 17
#2Bonnita Werner (UNSW: University of New South Wales)
Last. Kristina Warton (UNSW: University of New South Wales)H-Index: 12
view all 4 authors...
The build-up of fluid in the peritoneal cavity—ascites—is a hallmark of ovarian cancer, the most lethal of all gynaecological malignancies. This remarkable fluid, which contains a variety of cellular and acellular components, is known to contribute to patient morbidity and mortality by facilitating metastasis and contributing to chemoresistance, but remains largely under-researched. In this review, we will critically analyse the evidence associating ascites with metastasis and chemoresistance in...
Source
#1Shangyi Luo (HMU: Harbin Medical University)H-Index: 2
#2Yajing Zhang (Peking Union Medical College)
Last. Xiaobo Hou (HMU: Harbin Medical University)
view all 12 authors...
Abstract Objective Platinum-based chemotherapy remains the first-line treatment for ovarian carcinoma by inducing DNA damage. The therapeutic impact of clonal and subclonal somatic mutations in DNA damage repair (DDR) pathways remains unexplored. Methods We performed an integrated analysis to infer the clonality of somatic deleterious mutations in 385 ovarian carcinomas treated with platinum-based chemotherapy. The Kaplan–Meier method was performed for visualization and the differences between s...
Source
Source
#1Saya Jacob (NU: Northwestern University)H-Index: 1
Last. Young Kwang Chae (NU: Northwestern University)H-Index: 26
view all 3 authors...
Abstract Background Reversion mutations of somatic BRCA mutations are an important source of resistance within ovarian cancer. Furthermore, these reversion mutations are known to change over the course of treatment. Better understanding of the mechanisms leading to reversion mutations and the role of serial ctDNA collection in detecting changes to overall landscape of resistance mutations over time is needed to guide treatment in the metastatic setting. Methods Here we study a case of metastatic...
Source
#1Fangfang Song (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 1
#2Lian Li (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 2
Last. Luyang Liu (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 1
view all 13 authors...
Abstract Objective Extensive genetic and limited epigenetics have been characterized by the Cancer Genome Atlas (TCGA) among Western High-grade serous ovarian cancer (HGSOC). The present study aimed to characterize Chinese HGSOC at genome scale. Methods We used reduced representation bisulfite sequencing to investigate whole-genome and tumor-specific DNA methylation in 21 HGSOC tumors paired with their normal tissues, followed by a replication study involving additional 41 HGSOC patients. Altere...
Source
#1Jianfa Wu (University of Medicine and Health Sciences)H-Index: 1
#2Li Zhang (University of Medicine and Health Sciences)H-Index: 1
Last. Zhou Liu (University of Medicine and Health Sciences)H-Index: 1
view all 5 authors...
ABSTRACT Background miR-194-5p has been associated with drug resistance in many cancers. However, the role of miR-194-5p in cisplatin resistance in ovarian cancer is still unclear. Materials and methods To study the role and mechanism of miR-194-5p in cisplatin resistance, qRT-PCR was performed to determine the expression of miR-194-5p and SLC40A1 in ovarian cancer. Cell Counting Kit-8 (CCK8) assay was used to analyse cell viability after cisplatin treatment. Dual-luciferase reporter gene assay ...
Source